Behind the Scenes of the New Nova Scotia Pharmacy Agreements with Allison Bodnar & Rose Dipchand

In this episode, PANS' Lisa Woodill sits down with Allison Bodnar, PANS CEO, and Rose Dipchand, PANS Board member and Chair of the PANS Economics Committee, to break down Nova Scotia’s new Nova Scotia pharmacy agreements—Tariff Agreement, Pharmacy Services Agreement, and the first‑ever CPPCC Agreement. Find out how pharmacy contracts actually get negotiated (and why it’s not quick), what changed, why it matters, and what these changes mean for pharmacy teams and patient access to care across the province.Copyright NoticeBy accessing the PANS Pods and PANS Podcast (the “Podcast”) you acknowledge that the contents, design, and materials are the property of the Pharmacy Association of Nova Scotia (PANS) or used by PANS with permission. The Podcast and its data, content, information, and other materials are protected under Canadian copyright and trademark laws. The Podcast is for general educational purposes only. No other use, including, without limitation, reproduction, retransmission, or editing, may be made without the prior written permission of PANS.DisclaimerThe Podcast and content contained therein, including text, images, audio, or other formats, were created for general education and informational purposes only. The content is not intended to be a substitute for professional medical advice, clinical diagnosis, or treatment. Reliance on any information provided is solely at your own risk. Furthermore, any third-party materials or content of any third-party site referenced in the Podcast do not necessarily reflect the opinions, standards, or policies of PANS. PANS assumes no responsibility or liability for the accuracy or completeness of the content of guests or contained in third-party materials or on third-party sites referenced in this Podcast or the compliance with applicable laws of such materials and/or links referenced therein.Limitation of LiabilityPANS EXPRESSLY DISCLAIMS ANY AND ALL LIABILITY OR RESPONSIBILITY FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR OTHER DAMAGES, INCLUDING WITHOUT LIMITATION LOSS OF PROFITS, ARISING OUT OF ANY INDIVIDUAL'S USE OF, REFERENCE TO, RELIANCE ON, OR INABILITY TO USE THE PRODUCTS OR THE INFORMATION PRESENTED IN THE PODCASTS.